A breakthrough new treatment for disease could 'turn off' the gene that helps cause the disease, scientists hope. A trial currently taking place on 20 people, including four Brits, uses a new technology called 'RNA interference' which stops cells producing toxic proteins. It has so far found that a single dose of the 'gene silencing' treatment - currently known as ALN-APP - can cut the levels of a dangerous amyloid precursor protein by 90 per cent, with the levels still 65 per cent lower after six months.
Load More
Load More